We found that the increased expression of PAFAH1B3 was correlated with poor overall survival (OS) (P=0.0012) and disease-free survival (DFS) (P=0.0047) in HCC (Figures 2A, B). This evidence concerns the gene PAFAH1B3 and hepatocellular carcinoma.